Kindara is a women’s health startup focused on helping women track their primary fertility signs, like basal body temperature (BBT) and cervical fluid, to better visualize their cycle and gain insight into when they ovulate so that they can achieve their fertility goals. Simply put, Kindara helps women plan, anticipate issues, and ultimately achieve their fertility goals.
Kindara and other women’s health startups, often referred to as ‘femtech’, are changing how women manage, understand and interact about the topic of fertility. Femtech has evolved into a movement to empower women to learn about their bodies, providing insight to fertility issues and resulting in greater dialog between women and their doctors. Femtech companies, alongside Kindara, are continuously striving to fill in the voids often left by the traditional healthcare and reproductive health education women receive throughout their lives.
There’s no question that femtech companies are here to stay, as the sector continues to grow. Femtech companies, like Kindara, address the concerns of half the world’s population, so it’s not surprising that startups targeting women’s healthcare have multiplied in recent years (CB Insights), thus attracting attention and billions of VC investment dollars. The surprising fact, however, is that only 6% of all decision-makers at U.S. venture capital firms are women, according to data compiled by Fortune. Our team set out to empower women to learn more about their bodies, and now we’re taking it a step further - Kindara is offering its community the opportunity to invest in the future of women’s healthcare.
On April 5, 2012, the Jumpstart Our Business Startups (JOBS) Act was signed into law by President Barack Obama. Part of the legislation was aimed at making it easier for non-accredited people to invest in startups they are passionate about, potentially reaping the rewards of the next big hit. Prior to this private investment opportunities were limited to wealthy investors and venture capitalists.
According to a recent Venture Beat article, femtech startups fueled by new VC money rocket to the center of socio-political discussions, the tech industry’s role in women’s health may be more important now than ever. Kindara is excited to be a part of those discussions and to contribute to the advancement of the women’s health industry through technology. Kindara, a majority female company, believes that this investment opportunity will help get women more involved in two historically male-dominated industries: healthcare and technology.
There is reason to be confident investing in femtech. According to CB Insights, “the companies gaining ground in this sector — both in traditional healthcare and on the consumer side — are backed by some of the most high-profile investors out there. Digital health startups as a whole raised $5.8 billion from investors in 2015 and $3.5 billion in the first two quarters of 2016”.
Kindara is excited to be one of the first women’s health startups to offer an investment opportunity to our community. Our loyal app users and FAM fans know better than anyone the value Kindara brings to their lives, and we believe everyone should have the initial opportunity to invest in the growing market of women’s health startups.
With the help of SeedInvest, Kindara is offering the opportunity for accredited and non-accredited investors alike to invest and own shares in Kindara. The minimum investment is $1,000 and investments are limited. Your investment will go toward bringing more innovative products and services that women can use throughout their fertility journey.
Kindara is accepting reservations for an Offering under Tier II of Regulation A. No money or other consideration is being solicited, and if sent in response, it will not be accepted. No sales of securities will be made or commitment to purchase accepted until qualification of the offering statement by the Securities and Exchange Commission (the “Commission”) and approval of any other required government or regulatory agency. A reservation is non-binding and involves no obligation or commitment of any kind. No offer to buy securities can be accepted and no part of the purchase price can be received without an Offering Statement that has been qualified by the Commission. A Preliminary Offering Circular that forms a part of the Offering Statement has been filed with the Commission, a copy of which may be obtained from www.seedinvest.com/kindara/series.a.